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promising strategy against various infectious diseases.
Previously, it was demonstrated that passive immuniza-
tion by providing hyperimmune egg yolk through the feed
reduces Campylobacter jejuni colonization in broilers.
Campylobacteriosis is the most commonly reported bac-
terial foodborne zoonosis worldwide, and poultry products
are the number one origin of these bacteria for human
infection. To date, no effective control measures exist to
limit Campylobacter colonization in the chicken’s intesti-
nal tract. Here, the effect of lyophilization of hyperimmune
egg yolk on protection of broilers against C. jejuni was
investigated. During an in vivo trial, broiler chickens wereThe Authors. Published by Elsevier Inc. on behalf of
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2157prophylactically given feed with lyophilized hyperimmune
or non-immunized egg yolk powder starting from day 1
after hatch. At day 11, broilers were inoculated with
C. jejuni according to a seeder model. Five days later, all
broilers were euthanized and cecal content was examined
for C. jejuni colonization. No decrease in C. jejuni coloni-
zation was found. The freeze-drying resulted in a 16-fold
decrease of the antibody titer in the yolk powder
compared to the fresh yolks, presumably caused by struc-
tural changes in the antibodies. In conclusion, applying
freeze-dried hyperimmune egg yolk failed to protect
broilers against C. jejuni colonization, possibly because
lyophilization affected the antibodies’ functionality.Key words: Campylobacter, broiler, passive immunization, lyophilization, bacterin
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Oral administration of antibodies is a promising strategy
for controlling enteric bacterial and viral infections in
humans and animals, such as Salmonella enterica, Escher-
ichia coli, Campylobacter jejuni, Clostridium perfringens,
rotaviruses, and coronavirus (Mine and Kovacs-Nolan,
2002; Schade et al., 2005; Chalghoumi et al., 2009a;
Yegani and Korver, 2010; Gadde et al., 2015; Hedegaard
and Heegaard, 2016). A cost-efficient method to produce
such antibodies is through hyperimmunization of chickensand collecting the egg yolks, containing high amounts of
antibodies (Bizanov, 2017).
We recently demonstrated that passive immunization
using bacterin-induced antibodies was able to reduce C.
jejuni infection in broilers (Vandeputte et al., 2019a).
Campylobacter infection is the most commonly reported
bacterial foodborne zoonosis in the European Union
since 2005 (EFSA, 2017) and is mainly derived from
poultry products. In most cases, clinical symptoms
such as fever and diarrhea are self-limiting. However,
complications may occur, such as reactive arthritis
(Hannu et al., 2002) and Guillain-Barre syndrome
(Nachamkin, 2002). Unfortunately, no effective mea-
sures to control Campylobacter infection in poultry exist
to date (Hermans et al., 2011b). In our previous study
(Vandeputte et al., 2019a), vaccination of layer hens
resulted in a high and prolonged immune response,
observed as the presence of high amounts of anti-
Campylobacter IgY in the egg yolk. This hyperimmune
yolk was administered to the feed of the broilers at a
VANDEPUTTE ET AL.2158concentration of 5%, resulting in a decrease of infected
birds from 78 to 15%. However, under field conditions,
egg yolk as such cannot be implemented and therefore
an alternative administration method for these anti-
bodies should be developed.
Lyophilization of egg yolk results in an easy-to-mix
egg yolk powder (EYP) with an extended shelf-life.
Moreover, the yolk is considered to form a protective ma-
trix for the antibodies during their passage through the
gastrointestinal tract (Schade et al., 2005) and to
contain antimicrobial components (Kassaify and Mine,
2004a,b), so it would be advantageous to preserve
these beneficial characteristics. Here, we investigated if
we could obtain a colonization reduction similar to our
previous results using hyperimmune EYP.MATERIALS AND METHODS
Experimental Animals
Commercial Ross 308 broiler chickens of both sexes
were purchased at a local hatchery (Vervaeke-Belavi,
Tielt, Belgium). The animals were provided with a com-
mercial feed and water ad libitum. Husbandry, experi-
mental procedures, euthanasia methods, and biosafety
precautions were approved by the Ethical Committee
of the Faculty of Veterinary Medicine, Ghent Univer-
sity, Ghent, Belgium, and in accordance with the rele-
vant guidelines and regulations (EC2016/28). Birds
were proved to be free of Campylobacter by examination
of mixed fecal samples using standard methods as
described by Hermans et al. (2011a).Bacterial Strains and Culture Conditions
For the experimental infection, C. jejuni reference
strain KC40 from poultry origin was used, which colo-
nizes chickens to a high level (Van Deun et al., 2008).
Bacteria were routinely cultured in Nutrient Broth
No.2 (NB2, CM0067; Oxoid Ltd., Basingstoke, Hamp-
shire, UK) supplemented with Modified Preston
Campylobacter-selective supplement (SR0204 E;
Oxoid) and Campylobacter-specific growth supplement
(SR0232 E; Oxoid), at 42C for 17 h under microaerobic
conditions (5% O2, 5% CO2, 5% H2, 85% N2). C. jejuni
bacteria in the broth were enumerated by plating
tenfold dilutions in Hank’s Balanced Salt Solution
(HBSS; GIBCO-BRL, Invitrogen, Carlsbad, CA)
on modified charcoal cefoperazone deoxycholate
agar (mCCDA; CM0739; Oxoid) supplemented with
CCDA selective supplement (SR0155 E; Oxoid) and
Campylobacter-specific growth supplement (SR0232 E;
Oxoid), followed by microaerobic incubation at 42C
for 22 h.
Preparation of Hyperimmune Egg Yolk
Powder
Hyperimmune egg yolks against a bacterin mix of 13
genetically diverse C. jejuni and C. coli strains and eggyolks from sham-immunized hens were previously pro-
duced by Vandeputte et al. (2019a) and further pro-
cessed at the Flanders Research Institute for
Agriculture, Fisheries and Food (ILVO, Melle,
Belgium). Before lyophilization, the yolks were stored
at 4C. The yolks were frozen at 250C during 2 h and
then lyophilized (sublimation: 0.16 mbar, 20 h 250C
to 20C, 20 h at 20C; desorption: 0.025 mbar, 2 h
20C to 30C, 3 h at 30C; condenser temperature:
290C) in an Epsilon 2-10 D LSC freeze-drier (Martin-
Christ, Osterode am Harz, Germany). The hyperim-
mune and non-immunized EYP (resp. HEYP and
NEYP) was stored at 4C until further processing.Prophylactic Efficacy of In-Feed
Supplementation of Bacterin-Derived HEYP
on C. jejuni Cecal Colonization in Broilers
Fifty-four day-of-hatch Campylobacter free broilers
were raised in 2 randomly assigned treatment groups
(n 5 27/group) and housed in separate isolation units.
From the day of hatch until the end of the experiment,
the chicks were provided with feed containing 2.5%
(wt/wt) HEYP (group 1) or NEYP (group 2), mixed
manually through the feed. This concentration ap-
proaches the 5% egg yolk content used by Vandeputte
et al. (2019a). Groups-administered fresh hyperimmune
and non-immunized yolk were not repeated for ethical
reasons, to reduce the number of animals. Equal
amounts of feed and drinking water were provided for
each group during treatment and care was taken that
all animals had unlimited access to the feed and water.
At 10 D of age, the chicks of each group were randomly
assigned to 3 subgroups (n5 9/subgroup) and housed in
separate isolation units. At 11 D of age, 3 seeder chicks of
each subgroup were randomly selected and orally inocu-
lated with approximately 1! 105 cfu of C. jejuni strain
KC40, quantified by plating as described previously. The
birds that were not inoculated are referred to as senti-
nels. At day 16, all animals were euthanized by injection
of an overdose (100 mg/kg) sodium pentobarbital (Kela,
Hoogstraten, Belgium) in the wing vein, and the cecal
content was collected for C. jejuni enumeration (as
described in the following).Cecal C. jejuni Enumeration
Cecal C. jejuni enumeration was performed by qPCR
as described by Vandeputte et al. (2019b), originally
adapted from Lund et al. (2004) and Botteldoorn et al.
(2008). Briefly, DNA-extraction was performed using
the QIAamp Fast DNA Stool Mini Kit (Qiagen, Venlo,
the Netherlands) according to the manufacturer’s in-
structions, with the single adaptation that the DNA
was eluted in 100 mL instead of 200 mL ATE buffer.
The DNA was stored at 220C until further analysis.
Per qPCR reaction, 12.5 mL IQ Supermix (Bio-Rad,
Temse, Belgium), 0.25 mL of each primer (forward
primer Camp2F: 50 CACGTGCTACAATGGCATAT
RESEARCH NOTE 215930, reverse primer Camp2R: 50 GGCTTCATGCTCTC-
GAGTT 30), 0.25 mL probe (Camp2P: 50 6FAM-CAGA-
GAACAATCCGAACTGGGACA-BHQ1 30), 6.75 mL
HPLC-water, and 5 mL sample DNA were mixed until
a total volume of 25 mL. Primers and probe were pur-
chased at Integrated DNA Technologies (IDT; Leuven,
Belgium). After centrifuging for 1 min at 1,500 tpm,
the following qPCR program was run: 2 min at 50C,
10 min at 95C and 50 cycli of 15 s at 95C and 60 s at
60C (CFX96 Real-Time PCR Detection System, Bio-
Rad). The number of C. jejuni in the cecal content was
expressed as genomic equivalents (ge)/g cecal content.Determination of Egg Yolk IgY Titers
Campylobacter-specific IgY titers in egg yolks were
determined before and after lyophilization, as previously
described by Hermans et al., (2014) with minor changes
to the protocol. Egg yolks were diluted 1/5 (vol/vol) in
HBSS, mixed thoroughly, and incubated overnight at
4C. Lyophilized egg yolks were first diluted 1/2 (wt/
vol) in HBSS because half of the egg yolk consists of wa-
ter (Bizanov, 2017). The supernatant, containing the
water-soluble fraction of the egg yolk, was collected for
IgY quantification using ELISA. To determine egg
yolk IgY titers, 96-well flat bottom plates (Nunc Maxi-
Sorp, Nalge Nunc Int., Rochester, NY, USA) were
coated (24 h, 4C) with 106 cfu (before killing) bacterin
diluted in a 50 mL coating buffer (2.16 g Na2CO3.10H2O,
1.935 g NaHCO3 in 500 mL H2O). After washing (3!
HBSS, 1! washing buffer: 0.1% Tween-20 in PBS),
the wells were blocked (1 h, room temperature) with a
100 mL blocking buffer (1% BSA in washing buffer).
Next, 100 mL of a 1/2 dilution series of the supernatant
of the mixed egg yolks was incubated during 60 min at
room temperature. Plates were washed as described pre-
viously and incubated with 100 mL 1/10,000 horseradish
peroxidase–labeled anti-chicken IgY (Sigma Aldrich) in
a washing buffer during 90 min at room temperature.
After washing as described previously, the plates were
incubated with 50 mL 3,30,5,50-tetramethylbenzidine
substrate (Sigma Aldrich) for 10 min at room tempera-
ture in the dark. Next, 50 mL 0.5 M H2SO4 was added
to each well and the absorbance at 450 nm (OD450)
was measured using an automated spectrophotometer
(Pharmacia LKB Ultrospec III, Gemini BV, Apeldoorn,
Netherlands). IgY titers from yolks of immunized
hens were reported as the highest dilution where the
OD450 was greater than the OD450 1 3 standard
deviations of wells containing yolk originating from
sham-vaccinated birds.Figure 1. Individual and mean (─) cecal C. jejuni counts of colonized
broiler seeders () and sentinels (B) after prophylactic treatment with
lyophilized hyperimmune egg yolk. The birds received standard feed
supplemented with 2.5% (wt/wt) lyophilized egg yolk from either
sham-immunized (C1, C2, C3) or bacterin-immunized (B1, B2, B3)
layers, from day 1 until day 16 (the day of euthanasia). At 11 D of
age, seeder birds were inoculated with approximately 105 cfu C. jejuni
KC40. Values are represented as log10 ge/g cecal content.Statistical Analysis
Data of the in vivo trial were analyzed using R 3.3.1.
Before statistical analysis, C. jejuni counts were trans-
formed to log10 counts. The colonization data were
analyzed using a hurdle model, a class of models that as-
sumes that the data are generated by 2 processes. First,
the event that an individual is colonized (i.e., returning anon-zero count) follows a Bernoulli distribution. Given
colonization, its intensity or load is a random variable
following a discrete or continuous distribution; in this
case, a gamma distribution was assumed. The model
was used to estimate the probability of C. jejuni coloni-
zation and the mean C. jejuni numbers in the cecal con-
tent of colonized birds for each treatment level. Next, the
pairwise differences between those and the proportion of
the respective posterior distributions that had the same
sign as the mean were calculated. If working in a null-
hypothesis significance testing framework, this can be
interpreted as a one-sided test, estimating the probabil-
ity that the true difference between treatments is zero or
greater (if negative) or smaller (if positive), and thus the
level of confidence that the null hypothesis can be
rejected. For a detailed description of the implementa-
tion in R, reference is made to Vandeputte et al.,
(2019a).RESULTS
Protective Effect of Prophylactic Passive
Immunization of Broilers With Bacterin-
Derived HEYP Against Cecal C. jejuni
Colonization
C. jejuni counts per gram cecal content after eutha-
nasia of the chickens, prophylactically fed HEYP or
NEYP, are given in Figure 1. No significant reduction
of the number of C. jejuni colonized broilers was
observed in HEYP-treated subgroups compared to the
control subgroups (resp. 21/27, 24/27; P . 0.05). In
each subgroup of both treatments, all seeders were colo-
nized. The difference in the number of colonized birds be-
tween the 2 groups was a consequence of the variation in
C. jejuni transmission to the sentinel birds. Yet, this
reduction was not significant (resp. 12/18, 15/18;
VANDEPUTTE ET AL.2160P . 0.05). No significant decrease of the mean C. jejuni
counts in birds positive for colonization between the
HEYP-treated and control groups was found [resp.
4.87, 5.11 log10 (ge/g cecal content); P . 0.05], as well
as for seeders separately [resp. 5.79, 6.26 log10 (ge/g cecal
content); P . 0.05] or sentinels separately [resp. 4.18,
4.41 log10 (ge/g cecal content); P . 0.05].
Effect of Hyperimmune Egg Yolk
Lyophilization on Antibody Titers
The bacterin-induced Campylobacter-specific IgY
titer in the egg yolks before lyophilization was
1:65,536, as determined by ELISA. After lyophilization,
the antibody titer was reduced to 1:4,096.
DISCUSSION
In the present study, no protection against C. jejuni
colonization was detected in chickens fed HEYP
compared to control animals. This is in contrast to the
results of Hermans et al., (2014) and Vandeputte
et al., (2019a), the latter applying the same vaccines
and procedures as used in this study, but using fresh
yolks. A possible explanation is that lyophilization
resulted in a 16-fold decline of the Campylobacter-spe-
cific antibody titer in the yolk, as determined by ELISA.
Previously, Shimizu et al., (1988) found no effect of
lyophilization on IgY activity, whereas others showed
that freeze-drying resulted in some loss of antigen-
binding activity of IgY (Sunwoo et al., 2002). Lyophili-
zation of proteins induces freezing and dehydration
stresses, which may result in protein structural changes
or even unfolding (Emami et al., 2018). Therefore, to
protect the proteins against these stresses, these authors
recommend adding cryoprotectants and lyoprotectants.
As noted by Chalghoumi et al., (2009b) and Paul
et al., (2014), the initial antibody dose, when orally
administered, should be sufficiently high to ensure that
an adequate amount of functional antibodies survives
the gastrointestinal passage to establish protection
against bacterial colonization. It is possible that the
remaining titer after lyophilization (. 1:4.096) was
insufficient compared to the titers supplemented by
Vandeputte et al., (2019a) using fresh yolks
(. 1:64.536).
The need to protect the antibodies during the passage
through the gastrointestinal tract, against, for example,
the acidic stomach environment and proteases, has been
emphasized before (Schade et al., 2005; Chalghoumi
et al., 2009a). Egg yolk is considered to form a
protective matrix for the antibodies against
degradation and functionality loss during this passage
(Schade et al., 2005), but this protection might be
affected during the freeze-drying process. To further
investigate this hypothesis, further research will be
needed, for example, determination of the effect of fresh
yolk and lyophilized antibodies on the adherence of C.
jejuni to intestinal mucus, because it was demonstrated
previously that Campylobacter-specific antibodiesenhance mucosal binding (Hermans et al., 2014). Other
methods can be applied to increase stability of the anti-
bodies, such as microencapsulation; however, this would
increase the production complexity and cost
(Chalghoumi et al., 2009a).
In conclusion, it was demonstrated that administering
freeze-dried hyperimmune yolk did not protect broilers
against C. jejuni colonization, in contrast to a previous
study using fresh yolks. This is correlated with decreased
antigen binding after lyophilization and may be further
compromised by degradation during gastrointestinal
passage. Further research will be needed to develop an
industrially applicable method to administer these
antibodies.ACKNOWLEDGMENTS
This work was financed by a grant of Federal Public
Service for Health, Food Chain Safety and Environment
(FOD, Brussels, Belgium), Project RT14/4-
Campimmun.
The authors are grateful to Nathalie Van Ryssel-
berghe and Serge Verbanck (Department of Pathology,
Bacteriology and Avian Diseases, Faculty of Veterinary
Medicine, Ghent University, Merelbeke, Belgium) for
their cooperation during the in vivo trial and to Stefano
Canessa (Department of Pathology, Bacteriology and
Avian Diseases, Faculty of Veterinary Medicine, Ghent
University, Merelbeke, Belgium) for his cooperation for
the statistical analysis.
Except for the C. jejuni KC40, all Campylobacter
strains for bacterin development were kindly provided
by Dr. Nadine Botteldoorn (Sciensano, Brussels,
Belgium) and originate from the Project RF11/6241-
Campytrace, funded by the Federal Public Service for
Health, Food Chain Safety and Environment (FOD,
Brussels, Belgium).REFERENCES
Bizanov, G. 2017. IgY extraction and purification from chicken egg
yolk. J. Hell. Vet. Med. 68:265–272.
Botteldoorn, N., E. Van Coillie, V. Piessens, G. Rasschaert,
L. Debruyne, M. Heyndrickx, L. Herman, and W. Messens. 2008.
Quantification of Campylobacter spp. in chicken carcass rinse by
real-time PCR. J. Appl. Microbiol. 105:1909–1918.
Chalghoumi, R., Y. Beckers, D. Portetelle, and A. Thewis. 2009a. Hen
egg yolk antibodies (IgY), production and use for passive immu-
nization against bacterial enteric infections in chicken: a review.
Biotechnol. Agron. Soc. Envir. 13:295–308.
Chalghoumi, R., C. Marcq, A. Thewis, D. Portetelle, and
Y. Beckers. 2009b. Effects of feed supplementation with specific
hen egg yolk antibody (immunoglobin Y) on Salmonella species
cecal colonization and growth performances of challenged broiler.
Poult. Sci. 88:2081–2092.
EFSA. 2017. The European Union summary report on trends and
sources of zoonoses, zoonotic agents and food-borne outbreaks in
2016. EFSA J. 15:5077.
Emami, F., A. Vatanara, E. J. Park, and D. H. Na. 2018. Drying
technologies for the stability and bioavailability of bio-
pharmaceuticals. Pharmaceutics 10:131.
Gadde, U., T. Rathinam, and H. S. Lillehoj. 2015. Passive immuni-
sation with hyperimmune egg-yolk IgY as prophylaxis and therapy
for poultry diseases - a review. Anim. Health Res. Rev. 16:163–176.
RESEARCH NOTE 2161Hannu, T., L. Mattila, H. Rautelin, P. Pelkonen, P. Lahdenne,
A. Siitonen, andM. Leirisalo-Repo. 2002.Campylobacter-triggered
reactive arthritis: a population-based study. Rheumatology
41:312–318.
Hedegaard, C. J., and P.M. Heegaard. 2016. Passive immunisation, an
old idea revisited: Basic principles and application to modern
animal production systems. Vet. Immunol. Immunopathol.
174:50–63.
Hermans, D., A. Martel, K. Van Deun, F. Van Immerseel,
M. Heyndrickx, F. Haesebrouck, and F. Pasmans. 2011a. The
cinnamon-oil ingredient trans-cinnamaldehyde fails to target
Campylobacter jejuni strain KC 40 in the broiler chicken cecum
despite marked in vitro activity. J. Food Prot. 74:1729–1734.
Hermans, D., K. VanDeun,W.Messens, A.Martel, F. Van Immerseel,
F. Haesebrouck, G. Rasschaert, M. Heyndrickx, and
F. Pasmans. 2011b. Campylobacter control in poultry by current
intervention measures ineffective. Urgent Need Intensified
Fundamental Research 152:219–228.
Hermans, D., K. Van Steendam, E. Verbrugghe, M. Verlinden,
A. Martel, T. Seliwiorstow, M. Heyndrickx, F. Haesebrouck, L. De
Zutter, D. Deforce, and F. Pasmans. 2014. Passive immunization
to reduce Campylobacter jejuni colonization and transmission in
broiler chickens. Vet. Res. 45:27.
Kassaify, Z. G., and Y. Mine. 2004a. Effect of food protein supple-
ments on Salmonella enteritidis infection and prevention in laying
hens. Poult. Sci. 83:753–760.
Kassaify, Z. G., and Y. Mine. 2004b. Nonimmunized egg yolk powder
can suppress the colonization of Salmonella typhimurium,
Escherichia coli O157 : H7, and Campylobacter jejuni in laying
hens. Poult. Sci. 83:1497–1506.
Lund, M., S. Nordentoft, K. Pedersen, and M. Madsen. 2004. Detec-
tion of Campylobacter spp. in chicken fecal samples by real-time
PCR. J. Clin. Microbiol. 42:5125–5132.
Mine, Y., and J. Kovacs-Nolan. 2002. Chicken egg yolk antibodies as
therapeutics in enteric infectious disease: a review. J. Med. Food
5:159–169.Nachamkin, I. 2002. Chronic effects of Campylobacter infection.
Microb. Infect. 4:399–403.
Paul, N., S. Al-Adwani, R. Crespo, and D. H. Shah. 2014. Evaluation
of passive immunotherapeutic efficacy of hyperimmunized egg yolk
powder against intestinal colonization of Campylobacter jejuni in
chickens. Poult. Sci. 93:2779–2787.
Schade, K., E. G. Calzado, R. Sarmiento, P. A. Chacana,
J. Porankiewicz-Asplund, and H. R. Terzolo. 2005. Chicken egg
yolk antibodies (IgY-technology): a review of progress in produc-
tion and use in research and human and veterinary medicine.
Altern. Lab. Anim. 33:129–154.
Shimizu, M., R. C. Fitzsimmons, and S. Nakai. 1988. Anti-
Escherichia-coli immunoglobulin-Y isolated from egg-yolk of
immunized chickens as a potential food ingredient. J. Food Sci.
53:1360–1366.
Sunwoo, H. H., E. N. Lee, K. Menninen, M. R. Suresh, and
J. S. Sim. 2002. Growth inhibitory effect of chicken egg yolk anti-
body (IgY) onEscherichia coliO157 :H7. J. FoodSci. 67:1486–1494.
Vandeputte, J., A. Martel, S. Canessa, N. Van Rysselberghe, L. De
Zutter, M. Heyndrickx, F. Haesebrouck, F. Pasmans, and
A. Garmyn. 2019a. Reducing Campylobacter jejuni colonization in
broiler chickens by in-feed supplementation with hyperimmune egg
yolk antibodies. Sci. Rep. 9:8931.
Vandeputte, J., A. Martel, N. Van Rysselberghe, G. Antonissen,
M. Verlinden, L. De Zutter, M. Heyndrickx, F. Haesebrouck,
F. Pasmans, and A. Garmyn. 2019b. In ovo vaccination of chicks
againstCampylobacter jejuni using a bacterin and subunit vaccine.
Poult. Sci. 0:1–6.
Van Deun, K., F. Pasmans, R. Ducatelle, B. Flahou, K. Vissenberg,
A. Martel, W. Van den Broek, F. Van Immerseel, and
F. Haesebrouck. 2008. Colonization strategy of Campylobacter
jejuni results in persistent infection of the chicken gut. Vet.
Microbiol. 130:285–297.
Yegani, M., andD. R. Korver. 2010. Application of egg yolk antibodies
as replacement for antibiotics in poultry. Worlds Poult. Sci. J.
66:27–37.
